Insider · SEC Forms 3, 4, 5
CIK 1494730
All transactions
Every Form 4 row this person reported, newest first
Insider · SEC Forms 3, 4, 5
Every Form 4 row this person reported, newest first
Feeley Kevin (CIK 1944119) reported 112 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-09-18). Recent activity: Buy WGS (7,197 shares), Sell WGS (586 shares), Sell WGS (52 shares), Sell WGS (541 shares), Sell WGS (1,470 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-09-18 | GeneDx Holdings Corp. (WGS) | CHIEF FINANCIAL OFFICER | Buy | 7,197 | $0 |
| 2026-09-18 | GeneDx Holdings Corp. (WGS) | CHIEF FINANCIAL OFFICER | Sell | 586 | $55,235 |
| 2026-09-18 | GeneDx Holdings Corp. (WGS) | CHIEF FINANCIAL OFFICER | Sell | 52 | $4,961 |
| 2026-09-18 | GeneDx Holdings Corp. (WGS) | CHIEF FINANCIAL OFFICER | Sell | 541 | $52,423 |
| 2026-09-18 | GeneDx Holdings Corp. (WGS) | CHIEF FINANCIAL OFFICER | Sell | 1,470 | $144,457 |
| 2026-09-18 | GeneDx Holdings Corp. (WGS) | CHIEF FINANCIAL OFFICER | Sell | 1,079 | $106,816 |
| 2026-09-11 | GeneDx Holdings Corp. (WGS) | CHIEF FINANCIAL OFFICER | Buy | 2,462 | $0 |
| 2026-09-11 | GeneDx Holdings Corp. (WGS) | CHIEF FINANCIAL OFFICER | Sell | 1,285 | $108,220 |
| 2026-09-03 | GeneDx Holdings Corp. (WGS) | CHIEF FINANCIAL OFFICER | Buy | 717 | $0 |
| 2026-09-03 | GeneDx Holdings Corp. (WGS) | CHIEF FINANCIAL OFFICER | Sell | 372 | $31,188 |
| 2026-06-18 | GeneDx Holdings Corp. (WGS) | CHIEF FINANCIAL OFFICER | Sell | 2,106 | $128,108 |
| 2026-06-18 | GeneDx Holdings Corp. (WGS) | CHIEF FINANCIAL OFFICER | Sell | 760 | $45,410 |
| 2026-06-18 | GeneDx Holdings Corp. (WGS) | CHIEF FINANCIAL OFFICER | Buy | 7,197 | $0 |
| 2026-06-18 | GeneDx Holdings Corp. (WGS) | CHIEF FINANCIAL OFFICER | Sell | 863 | $53,074 |
| 2026-06-11 | GeneDx Holdings Corp. (WGS) | CHIEF FINANCIAL OFFICER | Buy | 2,462 | $0 |
| 2026-06-11 | GeneDx Holdings Corp. (WGS) | CHIEF FINANCIAL OFFICER | Sell | 1,266 | $68,073 |
| 2026-06-03 | GeneDx Holdings Corp. (WGS) | CHIEF FINANCIAL OFFICER | Buy | 717 | $0 |
| 2026-06-03 | GeneDx Holdings Corp. (WGS) | CHIEF FINANCIAL OFFICER | Sell | 369 | $19,092 |
| 2026-05-01 | GeneDx Holdings Corp. (WGS) | CHIEF FINANCIAL OFFICER | Buy | 754 | $0 |
| 2026-05-01 | GeneDx Holdings Corp. (WGS) | CHIEF FINANCIAL OFFICER | Sell | 392 | $25,554 |
| 2026-03-30 | GeneDx Holdings Corp. (WGS) | CHIEF FINANCIAL OFFICER | Buy | 16,250 | $0 |
| 2026-03-30 | GeneDx Holdings Corp. (WGS) | CHIEF FINANCIAL OFFICER | Sell | 2,485 | $152,306 |
| 2026-03-30 | GeneDx Holdings Corp. (WGS) | CHIEF FINANCIAL OFFICER | Sell | 961 | $59,899 |
| 2026-03-30 | GeneDx Holdings Corp. (WGS) | CHIEF FINANCIAL OFFICER | Sell | 2,520 | $159,466 |
| 2026-03-30 | GeneDx Holdings Corp. (WGS) | CHIEF FINANCIAL OFFICER | Sell | 995 | $64,277 |
Source: SEC Form 4 filings · as of 2026-09-18